xIPOmeter
Biocon Biologics
NewsHeat chart
- Week
- Month
- Year
- Media news
- Corp news
The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice
Company Valuation
- Valuation
- Share Price
- Cumulative Funding
The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.
News related to Biocon Biologics153
Biocon BiologicsBiocon Biologics to Present at the 43rd Annual J.P. Morgan ...
PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), will....
https://www.prnewswire.com/news-releases/biocon-biologics-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302346982.htmlBiocon BiologicsBIOCON BIOLOGICS GLOBAL PLCDL-NOTES 2024(24/29) REG.S ...
BIOCON BIOLOGICS GLOBAL PLCDL-NOTES 2024(24/29) REG.S (USG11185AA61) - All master data, key figures and real-time diagram....
https://markets.businessinsider.com/bonds/biocon_biologics_global_plcdl-notes_202424-29_regs-bond-2029-usg11185aa61Biocon BiologicsEuropean agency endorses approval of Biocon Biologics' biosimilar ...
BENGALURU: Biocon Biologics, a biosimilars company and subsidiary of Biocon, has announced that the European Medicines Agency's Committee for Medicinal ...
https://www.msn.com/en-in/health/health-news/european-agency-endorses-approval-of-biocon-biologics-biosimilar-ustekinumab/ar-AA1vZiBgBiocon BiologicsU.S. FDA Approves Biocon Biologics' YESINTEK™, Bmab 1200 ...
U.S. FDA Approves Biocon Biologics' YESINTEK™, Bmab 1200 Biosimilar to J&J's Stelara® (Ustekinumab). PR Newswire. BRIDGEWATER, N.J. and BENGALURU, India, Dec. 2 ...
https://www.morningstar.com/news/pr-newswire/20241202ny69006/us-fda-approves-biocon-biologics-yesintek-bmab-1200-biosimilar-to-jjs-stelara-ustekinumabBiocon BiologicsU.S. FDA Approves Biocon Biologics' YESINTEK™, Bmab 1200 ...
PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON),...
https://www.prnewswire.com/news-releases/us-fda-approves-biocon-biologics-yesintek-bmab-1200-biosimilar-to-jjs-stelara-ustekinumab-302319272.html
Show more (148)Investors4
Goldman Sachs
ADQTata CapitalTrue North